We are a specialty pharmaceutical company developing transformative therapies to advance the treatment of gastrointestinal (GI) disorders. We focus on developing treatments for GI disorders for which meaningful therapeutic innovation is required to satisfy unmet patient need and disease burden.
Today, our pipeline consists of two unique clinical stage therapies with the potential to bring benefit to millions of patients with ...
We are a specialty pharmaceutical company developing transformative therapies to advance the treatment of gastrointestinal (GI) disorders. We focus on developing treatments for GI disorders for which meaningful therapeutic innovation is required to satisfy unmet patient need and disease burden.
Today, our pipeline consists of two unique clinical stage therapies with the potential to bring benefit to millions of patients with chronic and debilitating GI disorders that are not adequately controlled.Gastroparesis is a common complication of diabetes, but there is also a significant idiopathic population
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.